Moolec Science SA

자세한 내용은 Moolec Science SA 회사

Moolec Science SA is a science-based food ingredient company. The Company focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. It operates in the United States, Europe, and South America. The Company's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.

회사 정보

회사 코드MLEC

회사 이름Moolec Science SA

상장일Jan 03, 2023

설립일2022

CEOMr. Robert M. Bennett

직원 수- -

유형Ordinary Share

회계 연도 종료Jan 03

주소17, Boulevard F.W. Raiffeisan

도시LUXEMBOURG

증권 거래소NASDAQ Capital Market Consolidated

국가Luxembourg

우편 번호2411

전화35226496565

웹사이트https://www.moolecscience.com/

회사 코드MLEC

상장일Jan 03, 2023

설립일2022

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Andrew D. Hamer

Independent Director

--

Mr. James W. Keyes

Independent Director

--

Mr. Jeffrey A. (Jeff) Rich

Independent Director

--

Mr. Robert M. Bennett

Chairman of the Board, Chief Executive Officer

--

Dr. Eric Ver Ploeg

President

--

Mr. William W. Bunker

Vice Chairman of the Board, Chief Financial Officer

--

Mr. Patrick Brandt

Vice President - Acquisitions, Corporate Development

--

이름

이름/직위

직위

주식 보유

변동

Mr. Andrew D. Hamer

Independent Director

--

Mr. James W. Keyes

Independent Director

--

Mr. Jeffrey A. (Jeff) Rich

Independent Director

--

Mr. Robert M. Bennett

Chairman of the Board, Chief Executive Officer

--

Dr. Eric Ver Ploeg

President

--

Mr. William W. Bunker

Vice Chairman of the Board, Chief Financial Officer

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주주

업데이트 시간: Fri, May 16

주주 통계

유형

주주 통계

주주

비율

Union Group Ventures Limited.

37.81%

Theo I SCSp

29.54%

Biotech Company LLC

7.26%

Bioceres Group PLC

1.50%

Bransfield (Kyle P)

0.87%

Other

23.02%

주주 통계

주주

비율

Union Group Ventures Limited.

37.81%

Theo I SCSp

29.54%

Biotech Company LLC

7.26%

Bioceres Group PLC

1.50%

Bransfield (Kyle P)

0.87%

Other

23.02%

유형

주주

비율

Corporation

76.10%

Individual Investor

2.06%

Hedge Fund

0.18%

Investment Advisor/Hedge Fund

0.10%

Investment Advisor

0.06%

Research Firm

0.03%

Other

21.47%

기관 주식 보유

업데이트 시간: Tue, Mar 4

보고 기간

기관 수

보유 주식

비율

변동

2025Q1

27

31.43M

78.34%

-15.31M

2024Q4

39

31.43M

81.74%

-17.08M

2024Q3

44

31.41M

81.67%

-17.61M

2024Q2

82

31.49M

81.90%

-25.98M

2024Q1

87

32.51M

86.40%

-12.56M

2023Q4

89

34.47M

91.94%

-12.80M

2023Q3

92

34.47M

91.94%

-13.00M

2023Q2

95

34.69M

93.17%

-13.08M

2023Q1

90

34.51M

92.71%

+17.12M

2022Q4

88

36.26M

97.35%

+19.18M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Union Group Ventures Limited.

15.17M

39.43%

--

Feb 06, 2025

Theo I SCSp

11.85M

30.81%

--

Jun 30, 2024

Biotech Company LLC

2.91M

7.57%

--

Jun 30, 2024

Bioceres Group PLC

600.83K

1.56%

--

Jun 30, 2024

Bransfield (Kyle P)

350.00K

0.91%

-685.00K

-66.18%

Jun 30, 2024

Lopez Lecube (Jose)

306.45K

0.8%

--

Jun 30, 2024

Salinas (Martin)

59.97K

0.16%

--

Jun 30, 2024

Hoogenkamp (Henk)

46.67K

0.12%

-27.00

-0.06%

Jun 30, 2024

Dhingra (Amit)

39.98K

0.1%

--

Jun 30, 2024

8.800USD